Carman Alenson
Comptroller/Controller/Auditor presso PRIME MEDICINE, INC.
Patrimonio netto: - $ in data 31/03/2024
Profilo
Carman Alenson is currently working as the Principal Accounting Officer at Prime Medicine, Inc. Ms. Alenson previously worked as the Executive Director-Accounting & Controller at AMAG Pharmaceuticals, Inc. from 2015 to 2016 and as the CAO, Vice President-Accounting, Treasury & Tax at Agios Pharmaceuticals, Inc. from 2016 to 2021.
Ms. Alenson obtained an undergraduate degree and an MBA from Boston University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
PRIME MEDICINE, INC.
-.--% | 21/02/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Carman Alenson
| Società | Posizione | Inizio |
|---|---|---|
| PRIME MEDICINE, INC. | Comptroller/Controller/Auditor | 01/08/2021 |
Precedenti posizioni note di Carman Alenson
| Società | Posizione | Fine |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 30/07/2021 |
| AMAG PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/10/2016 |
Formazione di Carman Alenson
| Boston University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| PRIME MEDICINE, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- Carman Alenson
